Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Collaboration save search
Advanced Health Intelligence Ltd Signs Collaboration Agreement with Bin Farhood International Business Management Group L.L.C
Published: 2023-09-08 (Crawled : 16:00) - globenewswire.com
AHI | $1.5 0.0% 12K
|
Health Technology
|
| O: -5.22%
H: 0.0%
C: 0.0%
management business health international group collaboration agreement
YourTango Announces Groundbreaking New Podcast, "Open Relationships: Transforming Together" in Collaboration with iHeartMedia
Published: 2023-10-05 (Crawled : 18:00) - prnewswire.com
IHRT 4 | $1.885 -3.33% 350K
|
Consumer Services
|
| O: -1.4%
H: 3.2%
C: -6.05%
collaboration
Warner Bros. Unscripted Television in Collaboration with iHeartPodcasts Debuts "Six Degrees with Kevin Bacon" on International Day of Charity
Published: 2023-09-08 (Crawled : 14:00) - prnewswire.com
IHRT 4 | $1.885 -3.33% 350K
|
Consumer Services
|
| O: 0.28%
H: 2.81%
C: -5.68%
day international collaboration
$ 169.82 Billion growth expected in Unified Communication and Collaboration Market | 46.81% YOY growth in 2021 amid COVID-19 Spread | North America to Notice Maximum Growth | Technavio
Published: 2021-05-15 (Crawled : 00:20) - prnewswire.com
EGHT | $2.2 -1.35% 380K
|
Technology Services
| Email alert
Add to watchlist
EGHT | $2.15 -3.59% 720K
|
Technology Services
| Email alert
Add to watchlist
AVYA | $0.021 1280.95% 0
|
Electronic Technology
| Email alert
Add to watchlist
covid collaboration communication growth
Global Unified Communication and Collaboration Market Report 2022: Focus on Microsoft, Cisco, Avaya Holdings and Zoom
Published: 2022-04-13 (Crawled : 13:00) - prnewswire.com
AVYA | $0.021 1280.95% 0
|
Electronic Technology
|
| O: -0.51%
H: 2.99%
C: 1.96%
MSFT F | $405.38 -1.57% 12M
|
Technology Services
|
| O: 0.24%
H: 2.07%
C: 1.73%
report collaboration communication market
Mosaic Art Fashion House Allison Eden Studios announces collaboration with furniture manufacturer Zuo Modern
Published: 2022-03-17 (Crawled : 12:00) - prnewswire.com
TCLRY | $0.001 1000.0% 140K
|
Manufacturing
|
| O: -18.18%
H: 31.11%
C: 31.11%
MAR | $236.82 -0.69% 970K
|
Consumer Services
|
| O: -1.14%
H: 0.54%
C: 0.53%
announces collaboration fashion collaboration
Principal Solar and Triad Pro Innovators to Collaborate on Electric Vehicle Energy Storage Solutions
Published: 2022-05-09 (Crawled : 22:00) - globenewswire.com
PSWW | $0.0018 500K
|
Utilities
|
| O: -0.43%
H: 0.87%
C: -8.7%
TPII | $0.001 25K
|
|
| O: 4.07%
H: 7.82%
C: 6.7%
solar solutions energy collaboration
Relief Announces That Collaboration Partner, Acer Therapeutics, was Issued U.S. Patent 11,202,767 Covering ACER-001 Methods of Use for Treatment of Urea Cycle Disorders and Maple Syrup Urine Disease
Published: 2022-02-01 (Crawled : 09:00) - biospace.com/
RLFTF | $1.4 1.3K
|
n/a
|
| O: -5.33%
H: 5.63%
C: 3.52%
acer-001 urea urine treatment order ces patent therapeutics disease collaboration
Relief Reports US Collaboration Partner Announces Expansion of Aviptadil US Expanded Access & Right to Try Programs for Patients w/COVID-19 Respiratory Failure who've Exhausted All Approved Therapies
Published: 2022-01-19 (Crawled : 10:00) - biospace.com/
RLFTF | $1.4 1.3K
|
n/a
|
| O: 1.51%
H: 3.09%
C: -1.37%
RLFTY | $1.4006 733.33% 100
|
n/a
|
| O: -6.53%
H: 3.29%
C: 3.29%
covid-19 aviptadil expansion program respiratory covid report collaboration
Relief Reports that its U.S. Collaboration Partner has Announced Receipt of Initial Report of Patient Safety and Survival from Right to Try Use of Aviptadil During Omicron Surge
Published: 2022-01-27 (Crawled : 11:00) - biospace.com/
RLFTF | $1.4 1.3K
|
n/a
|
| O: -0.4%
H: 3.91%
C: -4.18%
aviptadil report collaboration
Relief Reports that its U.S. Collaboration Partner has Announced the Filing of a Provisional Patent Application for Stable Compositions of Aviptadil Suitable for Human Use
Published: 2022-01-04 (Crawled : 10:00) - biospace.com/
RLFTF | $1.4 1.3K
|
n/a
|
| O: 8.45%
H: 6.1%
C: 6.1%
RLFTY | $1.4006 733.33% 100
|
n/a
|
| O: 10.09%
H: 0.0%
C: 0.0%
NRXP | News 0 d | $3.065 -26.67% 690K
|
Manufacturing
|
| O: 6.8%
H: 0.0%
C: 0.0%
aviptadil application patent collaboration
Relief Reports that its U.S. Collaboration Partner has Announced that the U.S. National Institutes of Health Study of Aviptadil in Critical COVID-19 is Cleared to Complete Full Enrollment
Published: 2022-02-16 (Crawled : 09:00) - biospace.com/
RLFTF | $1.4 1.3K
|
n/a
|
| O: -7.15%
H: 7.7%
C: 6.89%
covid-19 aviptadil health covid report collaboration enroll
Relief Reports that its U.S. Collaboration Partner has Announced that the I-SPY COVID Trial Suggests No Clinical Benefit with Addition of Nebulized Aviptadil in Critically Ill Patients with COVID-19
Published: 2022-04-01 (Crawled : 08:00) - biospace.com/
RLFTF | $1.4 1.3K
|
n/a
|
| O: -9.87%
H: 10.63%
C: 10.63%
NRXP | News 0 d | $3.065 -26.67% 690K
|
Manufacturing
|
| O: 0.82%
H: 0.77%
C: -2.02%
covid-19 covid collaboration aviptadil trial
Relief Reports that its U.S. Collaboration Partner Announces Data Safety Monitoring Board (DSMB) Update on the U.S. National Institutes of Health (NIH) Study of aviptadil in Critical COVID-19
Published: 2022-05-26 (Crawled : 12:00) - biospace.com/
RLFTF | $1.4 1.3K
|
n/a
|
| O: -9.48%
H: 4.19%
C: -39.05%
RLFTY | $1.4006 733.33% 100
|
n/a
|
| O: -40.54%
H: 20.91%
C: -15.45%
NRXP | News 0 d | $3.065 -26.67% 690K
|
Manufacturing
|
| O: -38.37%
H: 1.11%
C: -32.16%
covid-19 collaboration aviptadil health
Relief Reports that its U.S. Collaboration Partner has Filed a New Breakthrough Therapy Designation Request for Aviptadil
Published: 2022-04-22 (Crawled : 09:00) - biospace.com/
RLFTF | $1.4 1.3K
|
n/a
|
| O: -2.1%
H: 3.39%
C: -0.89%
NRXP | News 0 d | $3.065 -26.67% 690K
|
Manufacturing
|
| O: -15.09%
H: 1.67%
C: -5.56%
designation collaboration aviptadil therapy
Relief Reports that its U.S. Collaboration Partner has Announced an Update on Breakthrough Designation for Aviptadil
Published: 2022-06-13 (Crawled : 07:00) - biospace.com/
RLFTF | $1.4 1.3K
|
n/a
|
| O: -10.92%
H: 14.19%
C: -0.32%
NRXP | News 0 d | $3.065 -26.67% 690K
|
Manufacturing
|
| O: -8.21%
H: 7.26%
C: -3.08%
designation collaboration aviptadil
Relief Reports that its Collaboration Partner, Acer Therapeutics, Issued a Statement Regarding the PDUFA Target Action Date for ACER-001
Published: 2022-06-08 (Crawled : 10:00) - biospace.com/
RLFTF | $1.4 1.3K
|
n/a
|
| O: 7.26%
H: 4.17%
C: 0.26%
acer-001 pdufa collaboration
Relief Therapeutics Announces that its Collaboration Partner has Resubmitted the ACER-001 (Sodium Phenylbutyrate) New Drug Application (NDA) to the FDA for the Treatment of Urea Cycle Disorders (UCDs)
Published: 2022-07-18 (Crawled : 09:00) - biospace.com/
RLFTF | $1.4 1.3K
|
n/a
|
| O: 4.11%
H: 0.0%
C: -10.53%
acer-001 urea treatment fda drug collaboration application therapeutics
Relief Reports that its U.S. Collaboration Partner has Announced that the FDA has Declined Emergency Use Authorization for Aviptadil for a Subgroup of Patients with Critical COVID-19 at Immediate Risk
Published: 2022-07-04 (Crawled : 10:00) - biospace.com/
RLFTF | $1.4 1.3K
|
n/a
| Email alert
Add to watchlist
RLFTY | $1.4006 733.33% 100
|
n/a
| Email alert
Add to watchlist
NRXP | News 0 d | $3.065 -26.67% 690K
|
Manufacturing
| Email alert
Add to watchlist
covid-19 fda risk collaboration aviptadil authorization emergency use authorization
Relief Therapeutics Provides Update From Collaboration Partner on OLPRUVA
Published: 2023-03-15 (Crawled : 09:00) - biospace.com/
RLFTF | $1.4 1.3K
|
n/a
|
| O: -0.99%
H: 0.0%
C: 0.0%
ACER | $0.9 -3.61% 420K
|
Health Technology
|
| O: -2.4%
H: 2.45%
C: -1.84%
collaboration therapeutics update
Gainers vs Losers
| 68% | 32% |
Top 10 Gainers
AGBA | $1.05 162.5% 100M
|
Finance
ISPC | $0.4621 116.95% 15M
|
Professional, Scientific, and T...
INVO | $1.515 99.34% 4.3M
|
Health Technology
BPTH | $5.62 73.46% 75M
|
Health Technology
TIRX | $0.8231 69.78% 54M
|
XPON | $2.63 36.27% 8.4M
|
PRTG | $0.299 35.17% 120K
|
Mining, Quarrying, and Oil and ...
VTNR S | $1.26 28.68% 9.1M
|
Industrial Services
SWVL | $9.64 27.35% 200K
|
n/a
DFLI A | $0.7726 25.52% 4.3M
|
Your saved searches
Save your searches and get alerts when important news are released.